← Back to Search

eHealth Wellness Interventions for Multiple Sclerosis

N/A

Waitlist Available

Led By Ellen Mowry, MD

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18-89 years of age

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 1 month, 3 month

Awards & highlights

Study Summary

This trial is researching how to best communicate with MS patients about physical activity, sleep, and diet to improve their self-efficacy in managing the disease.

Who is the study for?

This trial is for adults aged 18-89 with Multiple Sclerosis who have an active MyChart account, seen at the Johns Hopkins MS Center within a year, and have an upcoming appointment. They must consent to questionnaires and randomization. It's not for those who've opted out of research or MyChart contacts.Check my eligibility

What is being tested?

The study tests if direct messages to patients after clinic visits can help them change their behavior regarding physical activity, sleep, and diet. It also looks at how these changes affect their self-efficacy in managing MS and overall patient-reported outcomes.See study design

What are the potential side effects?

Since this trial involves behavioral interventions through messaging rather than medication or medical procedures, there are no typical side effects like you'd expect from drugs; however, participants may experience stress or anxiety related to lifestyle changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 89 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 1 month, 3 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 1 month, 3 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 3 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in self-efficacy as assessed by the MS Self-Efficacy Scale (MSSE)

Secondary outcome measures

Change in Diet behavior Scores as assessed by the Mediterranean-DASH Intervention for Neurodegenerative Delay score (MIND Diet score)

Change in Reported physical activity as assessed by the Godin Leisure-Time Exercise Questionnaire (GLTEQ)

Change in Reported physical activity as assessed by the International Physical Activity Questionnaire (IPAQ) short form

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Wellness SmartphraseExperimental Treatment1 Intervention

This arm will receive a secure message after the conclusion of their standard clinic visit providing a set script containing information on a number of wellness-related topics in MS (sleep, diet, exercise).

Group II: No InterventionActive Control1 Intervention

This arm will not receive a secure message after their appointment, and will instead receive their standard care with their provider.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor

2,259 Previous Clinical Trials

14,820,533 Total Patients Enrolled

30 Trials studying Multiple Sclerosis

2,517 Patients Enrolled for Multiple Sclerosis

Pavan Bhargava, MDStudy DirectorJohns Hopkins University

1 Previous Clinical Trials

4 Total Patients Enrolled

1 Trials studying Multiple Sclerosis

4 Patients Enrolled for Multiple Sclerosis

Peter Calabresi, MDStudy DirectorJohns Hopkins University

3 Previous Clinical Trials

84 Total Patients Enrolled

2 Trials studying Multiple Sclerosis

40 Patients Enrolled for Multiple Sclerosis

Media Library

Wellness Patient Message Clinical Trial Eligibility Overview. Trial Name: NCT05442112 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this medical experiment still available?

"According to clinicaltrials.gov, this patient-seeking trial was first published on June 11th and updated most recently on the 16th of that same month."

Answered by AI

How many people are enrolled in this investigation?

"Affirmative. Clinicaltrials.gov indicates that the trial was posted on June 11th 2023 and has been actively searching for patients ever since, with its most recent update being June 16th 2023. The study is seeking to onboard 120 participants from a single clinical site."

Answered by AI

Does the trial accept participants below the age of 18?

"To be eligible for this research, individuals must fall between 18 and 89 years old. Meanwhile, there are also 25 trials specifically designed for minors under the age of 18 and 251 studies dedicated to seniors over 65."

Answered by AI

Is there a way for me to join this clinical trial?

"This medical study seeks 120 individuals between 18 and 89 years of age who have been diagnosed with multiple sclerosis. To be eligible, these patients must have visited the Johns Hopkins MS Precision Medicine Center of Excellence at least once during the past year and are scheduled for an upcoming appointment within three months. Additionally, a valid ICD10 code needs to appear twice in two distinct visits on either problem list or visit diagnosis fields to ensure accuracy. Furthermore, enrollees need to possess active MyChart accounts and agree to complete surveys as well as accept randomization selection process."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes

2023. "Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05442112.